Korean Circ J.  1992 Jun;22(3):396-402. 10.4070/kcj.1992.22.3.396.

The Effect of Enalapril in the Patients with the Chronic Severe Congestive Heart Failure

Abstract

ACE inhibitiors have been recently used to treat the chronic congestive heart failure after the use of the antihypertensive agents.The enalapril was added to the chronic congestive heart failure patients unresponded to diuretics and digoxin. The echocardiography, serum chemical examinations, ECG, chest X-ray and clinical manifestations were done to the 47 patients with chronic severe congestive heart failure unresponded to diuretics and digoxin before and 2 months after the addition of enalapril between Feb. 1991 and Nov. 1991 in Dong-A Univerity Hospital. The results were followed : 1) The dyspnea, the hepatomegaly, the engorged jugular vein, cough, edema, palpitation, chest discomfort, and the tachycardia were improved 2 months after the treatment of enalapril. 2) The cardiomegaly and lung edema on the chest PA, and the elevated GOT, GPT and serum creatinine were improved 2 months after the treatment of enalapril. 3) Left ventricular end systolic dimension, fractional shortening, left ventricular end diastolic volume, and ejection time on the ECHO were significantly increased after 2 months of the treatment of enalapril. ACE inhibitor, enalapril revealed the effectiveness of the treatment to the patients with the severe congestive heart failure, and we should try to study the mortality rates to decrease compared with the control groups without the treatment of enalapril.

Keyword

Enalapril; Congestive heart failure

MeSH Terms

Cardiomegaly
Cough
Creatinine
Digoxin
Diuretics
Dyspnea
Echocardiography
Edema
Electrocardiography
Enalapril*
Estrogens, Conjugated (USP)*
Heart Failure*
Hepatomegaly
Humans
Jugular Veins
Lung
Mortality
Stroke Volume
Tachycardia
Thorax
Creatinine
Digoxin
Diuretics
Enalapril
Estrogens, Conjugated (USP)
Full Text Links
  • KCJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr